NCT07244705 2025-11-24A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRCAnbogen Therapeutics, Inc.Phase 1/2 Recruiting66 enrolled
NCT07134101 2025-08-29SMARTi-RC01The First Affiliated Hospital with Nanjing Medical UniversityPhase 2 Not yet recruiting138 enrolled